Simultaneous detection of deletions of 9q and 22q in a subgroup of chronic myelocytic leukemia Philadelphia-positive patients by a novel probe

被引：3

作者：

Cohen, N ^{[1
]}

Amariglio, N

Rechavi, G

Trakhtenbrot, L

Hardan, I

机构：

[1] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel

[2] Chaim Sheba Med Ctr, Inst Hematol, IL-52621 Tel Hashomer, Israel

[3] Chaim Sheba Med Ctr, Dept Pediat Hematooncol, IL-52621 Tel Hashomer, Israel

来源：

CANCER GENETICS AND CYTOGENETICS | 2003年 / 141卷 / 01期

关键词：

D O I：

10.1016/S0165-4608(02)00649-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：89 / 90

页数：2

共 7 条

[1] Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene:: expression profiling, resistance to interferon therapy, and poor prognosis [J].

Cohen, N ;

Rozenfeld-Granot, G ;

Hardan, I ;

Brok-Simoni, F ;

Amariglio, N ;

Rechavi, G ;

Trakhtenbrot, L .

CANCER GENETICS AND CYTOGENETICS, 2001, 128 (02) :114-119

[2] Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy [J].

Dewald, GW ;

Wyatt, WA ;

Silver, RT .

LEUKEMIA & LYMPHOMA, 1999, 34 (5-6) :481-+

[3] Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis [J].

Kolomietz, E ;

Al-Maghrabi, J ;

Brennan, S ;

Karaskova, J ;

Minkin, S ;

Lipton, J ;

Squire, JA .

BLOOD, 2001, 97 (11) :3581-3588

[4] Heterogenic molecular basis for loss of ABL I-BCR transcription:: Deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABLI-positive chronic myeloid leukemia [J].

Loncarevic, IF ;

Römer, J ;

Starke, H ;

Heller, A ;

Bleck, C ;

Ziegler, M ;

Fiedler, W ;

Liehr, T ;

Clement, JH ;

Claussen, U .

GENES CHROMOSOMES & CANCER, 2002, 34 (02) :193-200

[5] Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals [J].

Mohr, B ;

Bornhäuser, M ;

Platzbecker, U ;

Freiberg-Richter, J ;

Naumann, R ;

Prange-Krex, G ;

Mohm, J ;

Kroschinsky, F ;

Ehninger, G ;

Thiede, C .

CANCER GENETICS AND CYTOGENETICS, 2001, 127 (02) :111-117

[6] High performance of the BCR/ABL-extra sensitive (ES) probe for detection of der(9q) deletion in t(9;22) (q34;q11.2) [J].

Najfeld, V .

CANCER GENETICS AND CYTOGENETICS, 2002, 132 (02) :171-171

[7] Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia [J].

Sinclair, PB ;

Nacheva, EP ;

Leversha, M ;

Telford, N ;

Chang, J ;

Reid, A ;

Bench, A ;

Champion, K ;

Huntly, B ;

Green, AR .

BLOOD, 2000, 95 (03) :738-744

← 1 →